A double-blind placebo-controlled phase III chemo-immunotherapy (paclitaxel-carboplatin-oregovomab [PCO]) vs. chemotherapy (paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5 study

Autor:	Myong Cheol Lim, Jung-Yun Lee, Yong-Man Kim, Michael Gold, Lucy Gilbert, Lukas Rob, Yong Beom Kim, Jae-Weon Kim, Peng-Hui Wang, Min Hwan Kim, Yu-Fang Huang, Chi-Feng Chung, Sunil Gupta, Srinivasa Rao Jada, Angeles Alvarez Secord
Rok vydání:	2023
Zdroj:	Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology.
DOI:	10.3802/jgo.2023.34.s1.tip06
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ac8275c925baf56a17f0484345a2d84b https://doi.org/10.3802/jgo.2023.34.s1.tip06 Zobrazit plný text záznamu